rsv
Mit dem nahenden Ende des Winters flachen die Wellen von Atemwegsinfektionen in Deutschland langsam ab. Die Zahl der Grippe-Fälle gehe zurück, auch bei der Zahl der RSV-Fälle deute sich ein Rückgang an, geht aus dem Bericht des Robert Koch-Instituts (RKI) vom Mittwochabend hervor. Dieser bezieht sich auf die Woche bis 25. Februar. RSV steht für Respiratorisches Synzytial-Virus, das insbesondere bei Kleinkindern diagnostiziert wurde. Die Grippe betrifft laut RKI derzeit immer noch alle Altersgruppen und führe zu einer erhöhten Zahl an Arztbesuchen und Krankenhauseinweisungen. Kurve geht leicht ...
DPA (German)
Washington (AFP) - The United States on Monday became the first country to approve a vaccine for pregnant women that prevents severe disease caused by Respiratory Syncytial Virus (RSV) in their babies. The Pfizer shot, which was already approved for use in older adults, has now been greenlighted for use as a single injection from 32 through 36 weeks of pregnancy, to protect infants from birth through six months, a statement by the Food and Drug Administration said. It is the latest in a succession of medicines recently approved against the common microbe, which causes tens of thousands of hos...
AFP
Washington (AFP) - The United States on Wednesday approved the world's first vaccine for the Respiratory Syncytial Virus (RSV), the culmination of a decades-long hunt to protect vulnerable people from the common illness. Drugmaker GSK's Arexvy was green-lighted for adults aged 60 and older, with similar shots from other makers including Pfizer and Moderna expected to follow soon. "Today's approval of the first RSV vaccine is an important public health achievement to prevent a disease which can be life-threatening," said senior US Food and Drug Administration (FDA) official Peter Marks in a st...
AFP
Washington (AFP) - The United States on Wednesday approved GSK's Arexy vaccine against Respiratory Syncytial Virus (RSV), which can cause severe pneumonia and bronchiolitis in infants and the elderly. It marks the first such approval globally, with similar vaccines from other makers including Pfizer expected to follow soon. "Today's approval of the first RSV vaccine is an important public health achievement to prevent a disease which can be life-threatening," said senior US Food and Drug Administration (FDA) official Peter Marks in a statement. RSV normally causes mild, cold-like symptoms, but...
AFP
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら